Onetti and Zucchella begin by unpacking the often-used ‘business model’ term, examining key elements of business model conceptualization and offering a three tier approach with a clear separation between the business model and strategy: focus, exploring the different activities carried out by the organization; locus, evaluating where organizational activities are centered; and modus, testing the execution of the organization’s activities. The business model thus defines the unique way in which a company delivers on its promise to its customers. The theory and applications adopt a global approach, offering business cases from a variety of biotech companies around the world.
Onetti and Zucchella begin by unpacking the often-used ‘business model’ term, examining key elements of business model conceptualization and offering a three tier approach with a clear separation between the business model and strategy: focus, exploring the different activities carried out by the organization; locus, evaluating where organizational activities are centered; and modus, testing the execution of the organization’s activities. The business model thus defines the unique way in which a company delivers on its promise to its customers. The theory and applications adopt a global approach, offering business cases from a variety of biotech companies around the world.

Business Modeling for Life Science and Biotech Companies: Creating Value and Competitive Advantage with the Milestone Bridge
212
Business Modeling for Life Science and Biotech Companies: Creating Value and Competitive Advantage with the Milestone Bridge
212Product Details
ISBN-13: | 9780415874748 |
---|---|
Publisher: | Taylor & Francis |
Publication date: | 03/17/2014 |
Series: | Routledge Studies in Innovation, Organizations and Technology , #35 |
Pages: | 212 |
Product dimensions: | 6.00(w) x 9.00(h) x (d) |